Applied Therapeutics Inc. (APLT) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	10-K	10-K	10-K	10-K	S-1/A
Total revenues [+]	0.0	0.0	0.0	0.0	0.0	3.7
Royalties						3.7
Revenue growth					-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	4.3
Gross profit	0.0	0.0	0.0	0.0	0.0	-0.6
Gross margin						-15.7%
Selling, general and administrative [+]	27.3	43.0	32.7	13.2	2.0	0.6
General and administrative	27.3	43.0	32.7	13.2	2.0	0.6
Research and development	55.6	62.6	61.8	32.4	11.5
Other operating expenses						3.1
EBIT [+]	-83.0	-105.6	-94.5	-45.6	-13.5	-4.3
EBIT growth	-21.5%	11.8%	107.2%	237.2%	215.5%
EBIT margin						-115.7%
Interest income, net [+]	0.7	0.6	0.6	0.1	-1.6	0.0
Interest expense					1.6
Interest income	0.7	0.6	0.6	0.1		0.0
Other income (expense), net [+]	-0.2	-0.5	-0.1	0.0	-1.4
Gain (loss) on debt retirement					-0.2
Change in fair value of warrants	-0.1
Other	-0.2	-0.5	-0.1	0.0	-1.1
Pre-tax income	-82.5	-105.6	-94.0	-45.5	-16.5	-4.3
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-82.5	-105.6	-94.0	-45.5	-16.5	-4.3
Net margin						-115.6%

Basic EPS [+]	($2.18)	($4.12)	($4.28)	($3.55)	($3.01)	($0.79)
Growth	-47.1%	-3.6%	20.6%	17.7%	280.4%
Diluted EPS [+]	($2.18)	($4.12)	($4.28)	($3.55)	($3.01)	($0.79)
Growth	-47.1%	-3.6%	20.6%	17.7%	280.4%

Shares outstanding (basic) [+]	37.8	25.6	22.0	12.8	5.5	5.4
Growth	47.8%	16.5%	71.2%	134.0%	1.4%
Shares outstanding (diluted) [+]	37.8	25.6	22.0	12.8	5.5	5.4
Growth	47.8%	16.5%	71.2%	134.0%	1.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.